|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12 Suppl
|
|
pubmed:dateCreated |
1998-1-2
|
|
pubmed:abstractText |
Because most patients with advanced non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) respond to radioimmunotherapy (RIT), the study was designed to evaluate the relationship between response and survival in patients treated with radiolabeled Lym-1.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
80
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2706-11
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9406728-Adult,
pubmed-meshheading:9406728-Aged,
pubmed-meshheading:9406728-Animals,
pubmed-meshheading:9406728-Antibodies, Monoclonal,
pubmed-meshheading:9406728-Female,
pubmed-meshheading:9406728-Humans,
pubmed-meshheading:9406728-Iodine Radioisotopes,
pubmed-meshheading:9406728-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:9406728-Lymphoma, Non-Hodgkin,
pubmed-meshheading:9406728-Male,
pubmed-meshheading:9406728-Mice,
pubmed-meshheading:9406728-Middle Aged,
pubmed-meshheading:9406728-Radioimmunotherapy,
pubmed-meshheading:9406728-Survival Rate
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Increased survival associated with radiolabeled Lym-1 therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
|
|
pubmed:affiliation |
Department of Internal Medicine, University of California Davis Medical Center, Sacramento, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.
|
